Relapsed Acute Lymphoblastic Leukemia (ALL) Terminated Phase 1 / 2 Trials for Dexamethasone (DB01234)
Also known as: Acute Lymphoblastic Leukemia, in Relapse / Relapsed ALL / Relapsed Acute Lymphoblastic Leukemia / Acute, relapsed Lymphoblastic Leukemia
| Indication | Status | Phase |
|---|---|---|
| DBCOND0069491 (Relapsed Acute Lymphoblastic Leukemia (ALL)) | Terminated | 1 / 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03705507 | International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia | Treatment |